Back
Zevra Therapeutics 10K Form
Buy
67
ZVRA
Zevra Therapeutics
Last Price:
9.44
Seasonality Move:
6.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ZVRA News And Ratings
See the #1 stock for the next 7 days that we like better than ZVRA
ZVRA Financial Statistics
Sales & Book Value
Annual Sales: | $27.46M |
---|---|
Cash Flow: | $-18.14M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.31 |
Price / Book: | 6.98 |
Profitability
EPS (TTM): | -2.11000 |
---|---|
Net Income (TTM): | $-89.66M |
Gross Margin: | $24.52M |
Return on Equity: | -159.89% |
Return on Assets: | -56.14% |
Zevra Therapeutics Earnings Forecast
Key Zevra Therapeutics Financial Ratios
- The Gross Profit Margin over the past 11 years for ZVRA is 89.28%.
- The Selling, General & Administrative Expenses for ZVRA have been equal to 124.96% of Gross Profit Margin.
- The Research & Development expenses have been 144.95% of Revenue.
- The Interest Expense is -3.26% of Operating Income.
- The Net Earning history of ZVRA is -167.69% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 5 years.
Zevra Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | ZVRA |
Website: | zevra.com |
Debt
Debt-to-Equity Ratio: | 0.84 |
---|---|
Current Ratio: | 2.88 |
Quick Ratio: | 2.82 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
ZVRA Technical Analysis vs Fundamental Analysis
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a Buy
The current Zevra Therapeutics [ZVRA] share price is $9.13. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.